A nanocomposite material formed by benzofulvene polymer nanoparticles loaded with a potent 5-HT3 receptor antagonist (CR3124)
Source abstract
Abstract
Poly-BF3a, a new hydrophobic polymer obtained by spontaneous polymerization of 1-methylene-3-phenyl-1H-indene, was found to give nanoparticles characterized by favorable shape and dimensions. Poly-BF3a nanoparticles were loaded with CR3124, a potent 5HT3 antagonist, as a drug model by desolvation methods either in the absence or in the presence of polyethylene glycol (PEG1000) as a wetting agent. The SEM studies showed that the introduction of CR3124 into the preparation led to a variable degree of aggregation–cementation, which afforded a sort of nanocomposite material. In the absence of PEG1000, the drug molecule was found to stay in the amorphous state (DSC studies) when its percentage is not higher than 10% by weight. In vitro release experiments showed that the formation and stability of the dispersion as well as the drug release were remarkably affected by the presence of PEG1000, demonstrating its beneficial effect to the nanoparticle morphology and disaggregation.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Polymer Synthesis and Characterization · Photochromic and Fluorescence Chemistry · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (20)
Show source-provided references
1. Amidi M, Romeijn SG, Borchard G et al (2006) Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 111:107–116. doi: 10.1016/j.jconrel.2005.11.01410.1016/j.jconrel.2005.11.014 ↗
2. Cappelli A, Anzini M, Vomero S (2002) Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand–receptor interaction modalities. Bioorg Med Chem 10:779–801. doi: 10.1016/S0968-0896(01)00332-710.1016/S0968-0896(01)00332-7 ↗
3. Cappelli A, Pericot Mohr G, Anzini M et al (2003) Synthesis and characterization of a new benzofulvene polymer showing a thermoreversible polymerization behavior. J Org Chem 68:9473–9476. doi: 10.1021/jo035104h10.1021/jo035104h ↗
4. Cappelli A, Anzini A, Vomero S et al (2005) New π-stacked benzofulvene polymer showing thermoreversible polymerization: studies in macromolecular and aggregate structures and polymerization mechanism. J Polym Sci A 43:3289–3304. doi: 10.1002/pola.2078310.1002/pola.20783 ↗
5. Cappelli A, Travagli V, Zanardi I et al (2006) Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist. J Pharm Sci 95:2706–2721. doi: 10.1002/jps.2070510.1002/jps.20705 ↗
6. Cappelli A, Galeazzi S, Giuliani G et al (2007) Structural manipulation of benzofulvene derivatives showing spontaneous thermoreversible polymerization. Role of the substituents in the modulation of polymer properties. Macromolecules 40:3005–3014. doi: 10.1021/ma062923610.1021/ma0629236 ↗
7. Chiou WL, Kyle LE (1979) Differential thermal, solubility, and aging studies on various sources of digoxin and digitoxin powder: biopharmaceutical implications. J Pharm Sci 68:1224–1229. doi: 10.1002/jps.260068100810.1002/jps.2600681008 ↗
8. Deng XM, Xiong CD, Cheng LM et al (1995) Studies on the block copolymerization of d, l-lactide and poly(ethylene glycol) with aluminum complex catalyst. J Appl Polym Sci 55:1193–1196. doi: 10.1002/app.1995.07055080610.1002/app.1995.070550806 ↗
9. Fessi H, Devissaguet JP, Puisieux F et al (1992) Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent: 5,118,528
10. Gref R, Minamitake Y, Peracchia MT et al (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600–160310.1126/science.8128245 ↗
11. FDA guideline (2000) Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Available at http://www.fda.gov/cder/guidance/3618fnl.htm . Last accessed October 2008
12. Lin YJ, Lemstra PJ, Nijenhuis AJ et al (1995) ABA type copolymers of lactide with poly(ethylene glycol). Kinetic, mechanistic, and model studies. Macromolecules 28:2124–213210.1021/ma00111a004 ↗
13. McGregor C, Saunders MH, Buckton G et al (2004) The use of high-speed differential scanning calorimetry (Hyper-DSC™) to study the thermal properties of carbamazepine polymorphs. Thermochim Acta 417:231–23710.1016/j.tca.2003.09.031 ↗
14. Mendichi R, Giacometti, Schieroni A (2001) Use of a multidetector size exclusion chromatography system for the characterization of complex polymers. In: Pandalai SG (ed) Current trends in polymer science, vol 6. Trans-World Research Network, Trivandrum, India, pp 17–32
15. Oster CG, Wittmar M, Bakowsky U et al (2006) DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method. J Control Release 111:371–38110.1016/j.jconrel.2005.12.004 ↗
16. Rafati H, Coombes AGA, Adler I et al (1997) Protein loaded PLG microparticles for oral administration: formulation, structural and release characteristics. J Control Release 43:89–10210.1016/S0168-3659(96)01475-7 ↗
17. United States Pharmacopoeia 30—National Formulary 25 (2007a) Buffer solutions. The United States Pharmacopoeial Convention, Twinbrook Parkway, Rockville, MD, pp 806–807
18. United States Pharmacopoeia 30—National Formulary 25 (2007b) Dissolution—Apparatus 2 (paddle apparatus). The United States Pharmacopoeial Convention, Twinbrook Parkway, Rockville, MD, pp 278–279
19. United States Pharmacopoeia 30—National Formulary 25 (2007c) The dissolution procedure: development and validation. The United States Pharmacopoeial Convention, Twinbrook Parkway, Rockville, MD, pp 579–584
20. Wyatt PJ (1993) Light scattering and the absolute characterization of macromolecules. Anal Chim Acta 272:1–4010.1016/0003-2670(93)80373-S ↗